Aptevo Therapeutics Inc. Capital Expenditures
Aptevo Therapeutics Inc. (APVO) reported Capital Expenditures of $29.00 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2024-03-05.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2024-03-05
- Aptevo Therapeutics Inc. payments to acquire property, plant, and equipment for the quarter ending 2022-12-31 was $0.00, a 100.00% decline year-over-year.
- Aptevo Therapeutics Inc. payments to acquire property, plant, and equipment for the quarter ending 2022-09-30 was $4.00K, a 69.23% decline year-over-year.
- Aptevo Therapeutics Inc. payments to acquire property, plant, and equipment for the quarter ending 2021-12-31 was $118.00K.
- Aptevo Therapeutics Inc. payments to acquire property, plant, and equipment for the quarter ending 2021-09-30 was $13.00K.
- Aptevo Therapeutics Inc. payments to acquire property, plant, and equipment for fiscal 2022 was $29.00K, a 95.93% decline from fiscal 2021.
- Aptevo Therapeutics Inc. payments to acquire property, plant, and equipment for fiscal 2021 was $713.00K, a 710.23% increase from fiscal 2020.
- Aptevo Therapeutics Inc. payments to acquire property, plant, and equipment for fiscal 2020 was $88.00K, a 42.48% decline from fiscal 2019.
- Aptevo Therapeutics Inc. payments to acquire property, plant, and equipment for fiscal 2019 was $153.00K, a 84.32% decline from fiscal 2018.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 12 month |
|---|---|---|---|---|
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | $4.00K derived: sum of 2 quarters · filed 2024-03-05 | $29.00K 10-K · filed 2024-03-05 | |
| 2022-09-30 | $4.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $29.00K 10-Q · filed 2023-11-14 | ||
| 2022-06-30 | $25.00K 10-Q · filed 2023-08-10 | |||
| 2021-12-31 | $118.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $131.00K derived: sum of 2 quarters · filed 2023-03-30 | $522.00K derived: sum of 3 quarters · filed 2023-03-30 | $713.00K 10-K · filed 2023-03-30 |
| 2021-09-30 | $13.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $404.00K derived: sum of 2 quarters · filed 2022-11-10 | $595.00K 10-Q · filed 2022-11-10 | |
| 2021-06-30 | $391.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $582.00K 10-Q · filed 2022-08-11 | ||
| 2021-03-31 | $191.00K 10-Q · filed 2022-05-12 | |||
| 2020-12-31 | $88.00K 10-K · filed 2022-03-24 | |||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | $0.00 derived: sum of 2 quarters · filed 2021-03-31 | $0.00 derived: sum of 3 quarters · filed 2021-03-31 | $153.00K 10-K · filed 2021-03-31 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | $0.00 derived: sum of 2 quarters · filed 2020-11-10 | $153.00K 10-Q · filed 2020-11-10 | $202.00K derived: sum of 4 quarters · filed 2020-11-10 |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | $153.00K 10-Q · filed 2020-08-14 | $202.00K derived: sum of 3 quarters · filed 2020-08-14 | $562.00K derived: sum of 4 quarters · filed 2020-08-14 |
| 2019-03-31 | $153.00K 10-Q · filed 2020-05-13 | $202.00K derived: sum of 2 quarters · filed 2020-05-13 | $562.00K derived: sum of 3 quarters · filed 2020-05-13 | $656.00K derived: sum of 4 quarters · filed 2020-05-13 |
| 2018-12-31 | $49.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-25 | $409.00K derived: sum of 2 quarters · filed 2020-03-25 | $503.00K derived: sum of 3 quarters · filed 2020-03-25 | $976.00K 10-K · filed 2020-03-25 |
| 2018-09-30 | $360.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $454.00K derived: sum of 2 quarters · filed 2019-11-07 | $927.00K 10-Q · filed 2019-11-07 | $1.22M derived: sum of 4 quarters · filed 2019-11-07 |
| 2018-06-30 | $94.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $567.00K 10-Q · filed 2019-08-09 | $864.00K derived: sum of 3 quarters · filed 2019-08-09 | $999.00K derived: sum of 4 quarters · filed 2019-08-09 |
| 2018-03-31 | $473.00K 10-Q · filed 2019-05-09 | $770.00K derived: sum of 2 quarters · filed 2019-05-09 | $905.00K derived: sum of 3 quarters · filed 2019-05-09 | $1.08M derived: sum of 4 quarters · filed 2019-05-09 |
| 2017-12-31 | $297.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18 | $432.00K derived: sum of 2 quarters · filed 2019-03-18 | $608.00K derived: sum of 3 quarters · filed 2019-03-18 | $1.40M 10-K · filed 2019-03-18 |
| 2017-09-30 | $135.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | $311.00K derived: sum of 2 quarters · filed 2018-11-14 | $1.10M 10-Q · filed 2018-11-14 | $1.68M derived: sum of 4 quarters · filed 2018-11-14 |
| 2017-06-30 | $176.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $970.00K 10-Q · filed 2018-08-09 | $1.55M derived: sum of 3 quarters · filed 2018-08-09 | $1.50M derived: sum of 4 quarters · filed 2018-08-09 |
| 2017-03-31 | $794.00K 10-Q · filed 2018-05-10 | $1.37M derived: sum of 2 quarters · filed 2018-05-10 | $1.33M derived: sum of 3 quarters · filed 2018-05-10 | $2.23M derived: sum of 4 quarters · filed 2018-05-10 |
| 2016-12-31 | $579.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-13 | $533.00K derived: sum of 2 quarters · filed 2018-03-13 | $1.44M derived: sum of 3 quarters · filed 2018-03-13 | $2.51M 10-K · filed 2018-03-13 |
| 2016-09-30 | -$46.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-13 | $862.00K derived: sum of 2 quarters · filed 2017-11-13 | $1.93M 10-Q · filed 2017-11-13 | $2.45M derived: sum of 4 quarters · filed 2017-11-13 |
| 2016-06-30 | $908.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-10 | $1.98M 10-Q · filed 2017-08-10 | $2.49M derived: sum of 3 quarters · filed 2017-08-10 | $2.93M derived: sum of 4 quarters · filed 2017-08-10 |
| 2016-03-31 | $1.07M 10-Q · filed 2017-05-12 | $1.59M derived: sum of 2 quarters · filed 2017-05-12 | $2.02M derived: sum of 3 quarters · filed 2017-05-12 | |
| 2015-12-31 | $515.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-31 | $953.00K derived: sum of 2 quarters · filed 2017-03-31 | $1.53M 10-K · filed 2017-03-31 | |
| 2015-09-30 | $438.00K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2016-11-14 | $1.01M 10-Q · filed 2016-11-14 | ||
| 2015-06-30 | $574.00K 10-Q/A · filed 2016-09-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B |